A new Pharmaceutical Benefits Scheme listing last week for dry eye product Cationorm ties into a quirky review of a new area of literature from United States researchers. 

While chlorpromazine’s use on people with schizophrenia has been overtaken by atypical antipsychotics, it is still used widely.

James Buckley, fitness fanatic and partner at LiveLife Pharmacy Port Douglas, is full speed into the expanded Queensland prescribing pilot.

A new therapy can delay progression to insulin-dependent type 1 diabetes.

A systematic review and meta-analysis found little evidence that cannabinoids improve outcomes for common conditions such as anxiety, post-traumatic stress disorder (PTSD) and other psychiatric disorders.

With medicine shortages continuing to be an issue for the foreseeable future, pharmacists share how they are managing patients’ conditions and expectations.